Viewing Study NCT06009861


Ignite Creation Date: 2025-12-24 @ 12:30 PM
Ignite Modification Date: 2025-12-27 @ 9:34 PM
Study NCT ID: NCT06009861
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-06-06
First Post: 2023-08-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer (NeoSPOT)
Sponsor: Peking University Hospital of Stomatology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module